| Date | Time | Source | Announcement |
|---|---|---|---|
| 01 Oct 2003 | 07:00 AM | Purchase of Own Securities | |
| 30 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 29 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 26 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 25 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 24 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 23 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 22 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 19 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 18 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 17 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 16 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 15 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 12 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 10 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 08 Sep 2003 | 04:00 PM | Director Shareholding | |
| 08 Sep 2003 | 07:00 AM | Symbicort | |
| 04 Sep 2003 | 05:15 PM | Director Shareholding | |
| 04 Sep 2003 | 07:00 AM | Purchase of Own Securities | |
| 01 Sep 2003 | 07:54 AM | Exanta Study | |
| 01 Sep 2003 | 07:01 AM | Atacand CHARM Study | |
| 27 Aug 2003 | 03:00 PM | Capital Group | |
| 13 Aug 2003 | 07:01 AM | Crestor | |
| 08 Aug 2003 | 01:30 PM | Patent Infringement - Mylan | |
| 24 Jul 2003 | 11:00 AM | Interim Results - part 2 0f 2 | |
| 24 Jul 2003 | 11:00 AM | Interim Results - part 1of 2 | |
| 23 Jul 2003 | 09:00 AM | Notice of Results | |
| 14 Jul 2003 | 11:15 AM | Exanta | |
| 10 Jul 2003 | 07:00 AM | Crestor | |
| 08 Jul 2003 | 04:00 PM | Director Shareholding | |
| 01 Jul 2003 | 01:30 PM | New Appointments | |
| 23 Jun 2003 | 09:36 AM | Exanta | |
| 23 Jun 2003 | 07:37 AM | Statement re Zoladex | |
| 02 Jun 2003 | 07:00 AM | Purchase of Own Securities | |
| 30 May 2003 | 07:00 AM | Purchase of Own Securities | |
| 28 May 2003 | 07:00 AM | Purchase of Own Securities | |
| 22 May 2003 | 07:00 AM | Purchase of Own Securities | |
| 21 May 2003 | 07:00 AM | Purchase of Own Securities | |
| 20 May 2003 | 07:01 AM | Crestor | |
| 20 May 2003 | 07:00 AM | Purchase of Own Securities | |
| 19 May 2003 | 12:00 PM | Director Shareholding | |
| 19 May 2003 | 07:00 AM | Purchase of Own Securities | |
| 15 May 2003 | 12:00 PM | Director Shareholding | |
| 13 May 2003 | 07:00 AM | Purchase of Own Securities | |
| 08 May 2003 | 03:00 PM | Capital Group | |
| 08 May 2003 | 07:00 AM | Purchase of Own Securities | |
| 06 May 2003 | 04:00 PM | Capital Group | |
| 06 May 2003 | 07:00 AM | Iressa | |
| 02 May 2003 | 11:59 AM | AGM Resolutiions | |
| 30 Apr 2003 | 04:24 PM | AGM Poll Votes |
AstraZeneca plc is a British-Swedish multinational pharmaceutical and biotechnology company with its headquarters at the Cambridge Biomedical Campus in Cambridge, England.
It has a portfolio of products for major diseases in areas including oncology, cardiovascular, gastrointestinal, infection, neuroscience, respiratory, and inflammation. It was involved in developing the Oxford–AstraZeneca COVID-19 vaccine.
Astra Zeneca share price launched at 605p in 1993.